I am a Clinical Professor of Medicine in the Clinical Health Sciences Tract. In addition to an active clinical practice in consultative general clinical cardiology, I also am medical director of the Electrocardiography Lab at Moffit/Long Hospitals, and the nations first UCSF Asian Heart & Vascular Center located on the Mount Zion Campus on the 2nd floor of the Hellman Building. My research interests are in health disparities primarily involving the Asian/Pacific Islander populations as well as clinical hypertension and prevention. I am currently PI of two Phase III industry sponsored trials with Roche Labs. The first one is with dalcetrapib - a CETP inhibitor that can raise HDL-Cholesterol in the ACS patient. The second is ALECARDIO which is evaluating a combined-balanced ppar alpha/gamma agent in type 2 diabetic patients presenting with ACS to the hospital. Another project is with an electrical engineer to develop a quantitative analysis of the standard 12-lead ECG at rest to determine if Q.E.D. (quantiative electrial dimension) analysis can reliably detect ischemia when compared to myocardial perfusion scan imaging.
Clinical hypertension and prevention